Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
101.06
+9.51 (10.39%)
At close: Aug 3, 2026, 4:00 PM EDT
101.00
-0.06 (-0.06%)
After-hours: Aug 3, 2026, 7:43 PM EDT

Twist Bioscience Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
-136.72-77.67-208.73-204.62-217.86-152.1
Depreciation & Amortization
25.3924.8531.4329.3116.519.75
Stock-Based Compensation
66.4764.4650.9330.2879.6637
Other Adjustments
-0.43-46.6646.863.572.662.49
Change in Receivables
-15.71-22.388.44-4.32-9.62-2.2
Changes in Inventories
-9.22-4.237.997.24-7.54-19.49
Changes in Accounts Payable
4.39.33-11.81-2.517.388.54
Changes in Accrued Expenses
5.893.3512.291.487.1210.51
Changes in Other Operating Activities
-22.121.33-1.5-2.9-2.7-6.74
Operating Cash Flow
-53.07-47.63-64.09-142.47-124.39-112.24
Operating Cash Flow Growth
------
Capital Expenditures
-40.05-28-5.08-27.78-101.86-27.06
Purchases of Investments
-59.6-49.39-51.91-76.35-217.64-58.8
Proceeds from Sale of Investments
59.5150.1453.91154.74100.48242.49
Cash Acquisitions
-----8.16-0.48
Proceeds from Business Divestments
-2.5---5.76-
Investing Cash Flow
-45.24-24.76-3.0750.61-232.93156.16
Long-Term Debt Repaid
-----1.56-3.33
Net Long-Term Debt Issued (Repaid)
-----1.56-3.33
Issuance of Common Stock
13.8213.5610.875.32279.85343.36
Repurchase of Common Stock
-0.02-0.02-3.98-4.41-7.75-10.85
Net Common Stock Issued (Repurchased)
13.813.546.890.91272.09332.52
Other Financing Activities
-15----
Financing Cash Flow
13.828.546.890.91270.53329.18
Foreign Exchange Rate Adjustments
0.180.140.13-0.03-0.320.02
Net Cash Flow
-84.34-43.71-60.15-90.98-87.1373.11
Free Cash Flow
-93.12-75.63-69.17-170.25-226.24-139.31
Free Cash Flow Growth
------
FCF Margin
-21.57%-20.08%-22.10%-69.46%-111.14%-105.27%
Free Cash Flow Per Share
-1.52-1.26-1.19-2.99-4.20-2.89
Levered Free Cash Flow
-172.54-71.05-175.4-199.78-300.5-179.92
Unlevered Free Cash Flow
-181.72-130.91-188.1-213.55-305.15-175.3
SEC Filings: 10-K · 10-Q